-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Tg Therapeutics, Inc. quarterly/annual Costs and Expenses history and growth rate from Q3 2022 to Q4 2024.
- Tg Therapeutics, Inc. Costs and Expenses for the quarter ending December 31, 2024 was $78.2M, a 38.6% increase year-over-year.
- Tg Therapeutics, Inc. Costs and Expenses for the twelve months ending December 31, 2024 was $287M, a 34.8% increase year-over-year.
- Tg Therapeutics, Inc. annual Costs and Expenses for 2024 was $287M, a 34.8% increase from 2023.
- Tg Therapeutics, Inc. annual Costs and Expenses for 2023 was $213M, a 3.65% decline from 2022.
- Tg Therapeutics, Inc. annual Costs and Expenses for 2022 was $221M, a 37.1% decline from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)